Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Regulatory News (N4P)

  • There is currently no data for N4P

Trading Statement

12 Feb 2013 07:00

RNS Number : 6491X
Ultima Networks PLC
12 February 2013
 



12 February 2013

 

ULTIMA NETWORKS PLC

("Ultima", "the Group" or the "Company") 

 

 

TRADING UPDATE

 

The Board of Ultima, the AIM listed IT and Green Technology company, is pleased to update its shareholders with a review of operation to the year ended 31 December 2012.

 

Ultima now operates through two divisions: the IT Services division, and the Green Technology division.

The IT Services division develops and supplies computer based application software and services to the legal profession. Progress during the year was stable, with clients continuing to migrate to the Company's new FiLos legal software suite. The adverse economic environment has seen the Company sign up a number of new "single partner" law firms, as larger practices reduce employee numbers. The Company is now offering monthly rental contracts for the software, which the Company expects to convert into larger sales contracts at some point in the future as the size of the new clients' practices grow. The division still provides a high level of recurring revenue for the Company.

The Green Technology division was restructured during 2012 and is responsible for the development and supply of electric powered bicycles under the brands "Powacycle" and "Infineum"; and also provides renewable energy solutions for the development of clean power generation through solar and other renewable power sources with installations in the UK and solar parks in Spain and under development in Italy.

During 2012 the Company highlighted an exciting project in Mexico where it would be working with the Mexican Department of Education to supply approx. 200kw of power through a specially developed hybrid PV system to over 100 schools. This pilot scheme is still under evaluation by the Mexican government and the Company is ready to roll out its systems as soon as the contract is signed. Finally, should the pilot phases be successful there is the opportunity for a significant number of schools across Mexico to join the scheme.

 

The total power output for the PV solar installations carried out by the Company in UK has now reached 1.1MW and the Company is looking to complete a number of local medium sized projects (over 50kw) in the coming months.

 

The Company's newly launched renewable heat solutions - Ground Source Heat and Air Source Heat - have had their first test installations in the UK to provide accreditation references. Ultima is one of the first UK suppliers of this environmentally friendly and novel home heating system to commence testing. The Department of Energy will launch, on 1 September 2013, its Renewable Heat Initiative ("RHI"), allowing users of this technology to receive a subsidy that will cover all installation costs over a period of 7 years.

 

In the interim results the Company expected an improvement in the sales of electric powered bicycles following a restructuring of its European distribution channel; however disappointingly, sales in the second half of the year were lower than expectated due to the on-going recession in mainland Europe. The Company is planning to launch its own subsidiary in Holland this month, to enable it to increase its brand awareness and stock a larger range of its cycles in situ. Benelux countries remain the Company's largest market in Europe and the new subsidiary is expected to grow brand recognition and position itself to take advantage of recovery in consumer confidence. In the UK, the over 50 age group is the key target audience and the Company expects that sales will increase once consumer spending rises.

 

Given the fall in demand for Ultima's electric powered bicycles in 2012 the Group's revenues for the full year will be lower than the previous financial year, however with the further investment in the developing of existing and potential new products, the Board believes the Group is now well positioned for growth.

 

 

Prof. Humayun Mughal, Chairman and CEO of Ultima, commented, 

 

"The Group's commitment to investment in the development of existing and potential new products and technologies has continued despite the backdrop of a continuation of tough economic and market conditions. Our intention is to ensure all divisions are well placed to take advantage of growth opportunities as business and consumer confidence returns.

 

"Uncertainties in the Eurozone resulted in a fall in demand for the Green Technology division's range of electrically assisted bicycles which has led to a review and subsequent improvement of the distribution channel and an expectation of a recovery in market share during 2013. The division also saw an increase in sales of PV renewable energy solutions and is in the process of extending its range of products by providing renewable heat installations and by developing its overseas markets by providing a range of customised renewable solutions into countries such as Mexico and Morocco. The IT Services division continues to roll out its FiLOS legal software suite increasing the size and scope of its customer base, and this is expected to continue during 2013 and is a direct result of the Group's investment in continuous product development."

 

 

 

Enquiries:

 

Ultima Networks plc 01279 821200

Prof. Humayun Mughal, Chairman and Chief Executive

 

Zeus Capital Limited(Nominated Adviser and Broker) 0161 831 1512

Nick Cowles

John Simpson

 

Leander(Financial PR) 07795 168157

Christian Taylor-Wilkinson

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDBGDDXBBBGXB
Date   Source Headline
17th Mar 202612:14 pmRNSResult of General Meeting and Change of Name
27th Feb 20267:00 amRNSNotice of GM and Proposed Change of Name
24th Feb 20267:00 amRNSCEO Appointment & Name Change Thalia Therapeutics
17th Dec 20257:00 amRNSBusiness and Operational Update
25th Sep 20257:00 amRNSInterim Results
23rd Sep 20257:00 amRNSPartnership with University of Strathclyde’s CMAC
22nd Sep 20257:00 amRNSN4 Pharma’s Nuvec® Targets Lung Cancer Cells
19th Sep 20257:00 amRNSNotice of Results, Analyst & Investor Presentation
11th Sep 20257:00 amRNS-RInvestor Event and Presentation
30th Jul 20251:55 pmRNS-RArticle on Nuvec®’s Potential in RNA Therapeutics
14th Jul 20257:00 amRNS-RInvestor Webinar
8th Jul 20257:00 amRNSDirectorate Change
30th Jun 20252:15 pmRNSResult of AGM
30th Jun 20257:00 amRNSAGM Statement
25th Jun 20257:00 amRNS-RInsight Event for Retail Investors
6th Jun 20257:00 amRNSFinal Results, Annual Report and Notice of AGM
27th May 20257:00 amRNS-REstablishment of New Senior Leadership Team
23rd May 202512:37 pmRNSTR-1: Notification of major holdings
21st May 20254:11 pmRNSHolding(s) in Company
15th May 20253:13 pmRNSChange of Registered Address
12th May 20257:00 amRNSN4 101 In Vivo Study Results
9th May 20258:24 amRNSHolding(s) in Company
29th Apr 20254:25 pmRNSHolding(s) in Company
29th Apr 202511:05 amRNSHolding(s) in Company
28th Apr 20252:30 pmRNSHolding(s) in Company
23rd Apr 20252:32 pmRNSTR-1: Standard form notification of major holdings
22nd Apr 202511:56 amRNSResult of General Meeting
4th Apr 20257:08 amRNSPosting of Circular and Notice of General Meeting
1st Apr 20254:08 pmRNSPlacing and Subscription to raise £1,750,000
18th Feb 202512:34 pmRNSHolding(s) in Company
7th Feb 20257:00 amRNS-RInvestor Webinar
27th Jan 20257:00 amRNS-RInvestor Webinar
16th Jan 20257:00 amRNS-RN4 Pharma Non-Executive Director Q&A
8th Jan 20257:00 amRNSDirectorate Changes
12th Dec 20247:00 amRNSN4 101 In Vitro Results
4th Dec 20247:00 amRNSNew Patent Filing
28th Nov 20247:00 amRNSGrant of Options
24th Sep 20247:00 amRNSInterim Results
17th Sep 20248:04 amRNSSRI Research Update
9th Sep 20247:00 amRNSDirector Appointment
23rd Aug 20248:30 amRNSChange of Auditor
20th Aug 20247:00 amRNSSRI Research Update
3rd Jul 20247:00 amRNSNanogenics Update
28th Jun 20247:00 amRNSTotal Voting Rights
19th Jun 20247:00 amRNSHolding(s) in Company
18th Jun 202412:34 pmRNSHolding(s) in Company
13th Jun 20244:52 pmRNSHolding(s) in Company
11th Jun 202411:16 amRNSNew Corporate Presentation
7th Jun 202410:18 amRNSPlacing and Subscription to raise £630,000
23rd May 20244:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.